"The interest in our equipment and therapies designed shown by distributors and prospective partners is the basis of our positive evaluation of Medica 2011. Moreover, we received thanks also to requests for collaboration in new countries through some Distributors of ours, which acted as testimonials of ASAlaser’s success: an important sign of proactivity of the relationship between the company and its dealers".
This is the opinion of Lucio Zaghetto - CEO of ASAlaser - about feedback obtained during the International Fair of Medicine and Technology Hospital of Düsseldorf which represents an important chance for ASAlaser to meet all its partners, to show the redesign of the corporate brand (ASAlaser - Research and Therapeutic Solutions) as well as two high-tech solutions bound to leave their mark: TOUCH 1.0 and iPad application.
"If TOUCH 1.0 was received with enthusiasm, thanks to the familiarity generated by MLS® software and to the possibility of getting a translated version for each country - explains Guido Ciranna, Export Sales Manager ASAlaser - the app. for iPad has won all partners". As tool for transmission of knowledge and training between ASAlaser and its distributors, the iPad is a further sign of the vocation to innovate of the company.
"Scientific and Technological Research – says Roberto Marchesini, Managing Director of ASAlaser - and therapeutic solutions based on the use of lasers and magnetic fields have been the basis of our business for almost 30 years: TOUCH 1.0 and iPad application are the natural evolution of our vocation, further highlighted by our brand and its pay-off, aimed to briefly describe our mission and core business".
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.